DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

Published:2010-01 Issue:1 Volume:17 Page:13-27
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Figueroa Maria E.,Lugthart Sanne,Li Yushan,Erpelinck-Verschueren Claudia,Deng Xutao,Christos Paul J.,Schifano Elizabeth,Booth James,van Putten Wim,Skrabanek Lucy,Campagne Fabien,Mazumdar Madhu,Greally John M.,Valk Peter J.M.,Löwenberg Bob,Delwel Ruud,Melnick Ari

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference33 articles.

1. Semi-supervised methods to predict patient survival from gene expression data;Bair;PLoS Biol.,2004

2. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield;Cancer Res.,1998

3. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing;Cameron;Blood,1999

4. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia;Christiansen;Leukemia,2003

5. The ade4 package - I: One-table methods;Chessel;R News,2004

Cited by 688 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune control in acute myeloid leukemia;Experimental Hematology;2024-10

2. Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias;Blood;2024-09-12

3. The DNA methylation landscape across the TCR loci in patients with acute myeloid leukemia;International Immunopharmacology;2024-09

4. Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties;Leukemia;2024-08-21

5. Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics;JCO Clinical Cancer Informatics;2024-07